Brokerages Set Oscar Health, Inc. (NYSE:OSCR) Price Target at $13.50

Shares of Oscar Health, Inc. (NYSE:OSCR) have been assigned a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $13.50.

Several analysts have issued reports on the stock. Raymond James assumed coverage on shares of Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 price target on the stock. Wells Fargo & Company upped their price target on shares of Oscar Health from $12.00 to $20.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. The Goldman Sachs Group upped their price target on shares of Oscar Health from $8.00 to $16.00 and gave the company a “neutral” rating in a research note on Friday, February 9th. Finally, TheStreet upgraded shares of Oscar Health from a “d” rating to a “c-” rating in a research note on Wednesday, February 21st.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Voya Investment Management LLC raised its holdings in Oscar Health by 1.7% during the 4th quarter. Voya Investment Management LLC now owns 62,955 shares of the company’s stock worth $576,000 after purchasing an additional 1,064 shares during the last quarter. American International Group Inc. grew its position in Oscar Health by 1.6% in the 4th quarter. American International Group Inc. now owns 78,402 shares of the company’s stock valued at $717,000 after purchasing an additional 1,199 shares during the period. Amalgamated Bank grew its position in Oscar Health by 10.6% in the 3rd quarter. Amalgamated Bank now owns 15,762 shares of the company’s stock valued at $88,000 after purchasing an additional 1,516 shares during the period. Price T Rowe Associates Inc. MD grew its position in Oscar Health by 3.8% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 45,022 shares of the company’s stock valued at $295,000 after purchasing an additional 1,651 shares during the period. Finally, Rhumbline Advisers grew its position in Oscar Health by 0.8% in the 3rd quarter. Rhumbline Advisers now owns 236,775 shares of the company’s stock valued at $1,319,000 after purchasing an additional 1,832 shares during the period. Institutional investors own 75.70% of the company’s stock.

Oscar Health Stock Up 5.9 %

Shares of NYSE OSCR opened at $15.68 on Friday. The stock has a market cap of $3.60 billion, a P/E ratio of -13.07 and a beta of 1.79. The firm has a 50 day moving average price of $15.25 and a 200 day moving average price of $10.68. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. Oscar Health has a 52-week low of $4.72 and a 52-week high of $18.55.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Wednesday, February 7th. The company reported ($0.66) earnings per share for the quarter, beating the consensus estimate of ($0.74) by $0.08. The company had revenue of $1.43 billion during the quarter, compared to analysts’ expectations of $1.43 billion. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The business’s quarterly revenue was up 43.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($1.05) earnings per share. Analysts expect that Oscar Health will post -0.23 EPS for the current year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.